Latest News about Psychedelics Research
Recent news which mentions Psychedelics Research
From Benzinga
DEA's Case For Scheduling Psychedelics Challenged In Landmark Hearing
November 20, 2024
Tickers
NEWS
From Benzinga
Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
November 19, 2024
From Benzinga
New Study Charts Adverse Events In Psychedelic-Assisted Therapies
November 14, 2024
Tickers
NEWS
From Benzinga
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
November 13, 2024
From Benzinga
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
November 13, 2024
From Benzinga
Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments
November 12, 2024
Tickers
NEWS
From Benzinga
From Benzinga
UK Breaks New Ground With First Government-Backed Psilocybin Therapy For Opioid Crisis
November 07, 2024
From Benzinga
Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health
November 06, 2024
From Benzinga
Americans Favor Psilocybin For Mental Health Treatment, Study Finds
November 05, 2024
From Benzinga
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
October 31, 2024
From Benzinga
From Benzinga
Psychedelic Drug DOI Pinpoints Anxiety Circuits Avoiding Hallucinogenic Effects, Study Finds
October 28, 2024
Tickers
NEWS
From Benzinga
From Benzinga
How Psychedelic Experiences Affect Couples: New Study Looks Into It
October 17, 2024
Tickers
MDMA
From Benzinga
From Benzinga
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis
October 17, 2024
From Benzinga
Awakn Partners With University Of Nottingham For Preclinical Testing Of Psychoactive Therapy
October 15, 2024
From Benzinga
From Benzinga
The Optimism Experiment: Psilocybin's Impact On Motivation
October 10, 2024
Tickers
NEWS
From Benzinga
Can LSD Therapy Calm Anxious Dogs? First-Of-Its-Kind Study Uncovers New Possibilities
September 27, 2024
From Benzinga
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
September 26, 2024
From Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
From Benzinga
DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
September 24, 2024
Tickers
NEWS
From Benzinga
Podcast - Intro To A Toll-Free Psychedelics Information Line, An Educational Tool By Unlimited Sciences
April 29, 2024
Tickers
NEWS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.